{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:34:44Z","timestamp":1780965284512,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T00:00:00Z","timestamp":1343952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00701-012-1450-x","type":"journal-article","created":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T18:45:55Z","timestamp":1343846755000},"page":"1889-1893","source":"Crossref","is-referenced-by-count":34,"title":["Transsphenoidal surgery for microprolactinomas in women: results and prognosis"],"prefix":"10.1007","volume":"154","author":[{"given":"Arimantas","family":"Tamasauskas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kestutis","family":"Sinkunas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adomas","family":"Bunevicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrius","family":"Radziunas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daina","family":"Skiriute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vytenis P.","family":"Deltuva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,3]]},"reference":[{"key":"1450_CR1","volume-title":"Review of pregnancy reports in patients on pergolide treatment","author":"V Acharya","year":"2004","unstructured":"Acharya V (2004) Review of pregnancy reports in patients on pergolide treatment. Eli Lilly, Co., Indianapolis"},{"key":"1450_CR2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3171\/jns.2002.97.2.0307","volume":"97","author":"AP Amar","year":"2002","unstructured":"Amar AP, Couldwell WT, Chen JCT, Weiss MH (2002) Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery. J Neurosurg 97:307\u2013314","journal-title":"J Neurosurg"},{"key":"1450_CR3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","volume":"65","author":"FF Casanueva","year":"2006","unstructured":"Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Fideleff H, Hadani M, Kelly P, Kleinberg D, Laws E, Marek J, Scanlon M, Sobrinho LG, Wass JA, Giustina A (2006) Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol 65:265\u2013273","journal-title":"Clin Endocrinol"},{"key":"1450_CR4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1042-3680(02)00090-6","volume":"14","author":"WT Couldwell","year":"2003","unstructured":"Couldwell WT, Rovit RL, Weiss MH (2003) Role of surgery in the treatment of microprolactinomas. Neurosurg Clin N Am 14:89\u201392","journal-title":"Neurosurg Clin N Am"},{"key":"1450_CR5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"Gillam MP, Molitch ME, Lombardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocrinol Rev 27:485\u2013534","journal-title":"Endocrinol Rev"},{"key":"1450_CR6","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3171\/jns.1999.90.6.1037","volume":"90","author":"R Guieu","year":"1999","unstructured":"Guieu R, Dufour H, Grisoli F, Jaquet P, Guieu Y, Rosso JP, Munier M, Dicostanzo V, Brue T, Enjalbert A, Begoud D, Rochat H (1999) An ultrarapid prognostic index in microprolactinoma surgery. J Neurosurg 90:1037\u20131041","journal-title":"J Neurosurg"},{"issue":"1","key":"1450_CR7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11102-005-5086-1","volume":"8","author":"DK Hamilton","year":"2005","unstructured":"Hamilton DK, Vance ML, Boulos PT, Laws ER (2005) Surgical outcoms in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists. Pituitary 8(1):53\u201360","journal-title":"Pituitary"},{"key":"1450_CR8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/mds.20201","volume":"19","author":"J Horvath","year":"2004","unstructured":"Horvath J, Fross RD, Kleiner-Fisman G, Lerch R, Stalder H, Liaudat S, Raskoff WJ, Flachsbart KD, Rakowski H, Pache JC, Burkhard PR, Lang AE (2004) Severe multivalvular heart disease: a new complication of the ergot derivate dopamine agonists. Mov Disord 19:656\u2013662","journal-title":"Mov Disord"},{"key":"1450_CR9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJM198003273021313","volume":"302","author":"DG Kissner","year":"1980","unstructured":"Kissner DG, Jarrett JC (1980) Side effects of bromocriptine. N Engl J Med 302:749\u2013750","journal-title":"N Engl J Med"},{"key":"1450_CR10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-07-0248","volume":"158","author":"J Kreutzer","year":"2008","unstructured":"Kreutzer J, Buslei R, Wallaschofski H, Hofmann B, Nimsky C, Fahlbusch R, Buchfelder M (2008) Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol 158:11\u201318","journal-title":"Eur J Endocrinol"},{"key":"1450_CR11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(82)92756-8","volume":"2","author":"AM Landolt","year":"1982","unstructured":"Landolt AM, Keller PJ, Froesch ER, Mueller J (1982) Bromocriptine: does it jeopardise the result of later surgery for prolactinomas? Lancet 2:657\u2013658","journal-title":"Lancet"},{"key":"1450_CR12","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1210\/jc.87.7.3180","volume":"87","author":"M Losa","year":"2002","unstructured":"Losa M, Mortini P, Barzaghi R, Giola I, Giovanelli M (2002) Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome. J Clin Endocrinol Metab 87:3180\u20133186","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1022375429083","volume":"5","author":"ME Molitch","year":"2002","unstructured":"Molitch ME (2002) Medical management of prolactin-secreting pituitary adenomas. Pituitary 5:55\u201365","journal-title":"Pituitary"},{"issue":"Suppl 3","key":"1450_CR14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3171\/jns.2000.93.supplement_3.0010","volume":"93","author":"L Pan","year":"2000","unstructured":"Pan L, Zhang N, Wang EM, Wang BJ, Dai JZ, Cai PW (2000) Gamma knife radiosurgery as primary treatment for prolactinomas. J Neurosurg 93(Suppl 3):10\u201313","journal-title":"J Neurosurg"},{"key":"1450_CR15","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1056\/NEJM200511033531822","volume":"353","author":"A Pinero","year":"2005","unstructured":"Pinero A, Marcos-Alberca P, Fortes J (2005) Cabergoline-related severe restrictive mitral regurgitation. N Engl J Med 353:1976\u20131977","journal-title":"N Engl J Med"},{"key":"1450_CR16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00003495-199549020-00009","volume":"49","author":"CP Rains","year":"1995","unstructured":"Rains CP, Bryson HM, Cabergoline FA (1995) A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation. Drugs 49:255\u2013279","journal-title":"Drugs"},{"key":"1450_CR17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000180100","volume":"22","author":"JP Raymond","year":"1985","unstructured":"Raymond JP, Goldstein E, Konopka P, Leleu MF, Merceron RE, Loria Y (1985) Follow-up of children born of bromocriptine-treated mothers. Horm Res 22:239\u2013246","journal-title":"Horm Res"},{"key":"1450_CR18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1056\/NEJM198308043090505","volume":"309","author":"O Serri","year":"1983","unstructured":"Serri O, Rasio E, Beauregard H, Hardy J, Somma M (1983) Recurrence of hyperprolactinemia after selective transsphenoidal adenectomy in women with prolactinoma. N Engl J Med 309:280\u2013282","journal-title":"N Engl J Med"},{"key":"1450_CR19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3171\/jns.2002.97.2.0299","volume":"97","author":"RK Shristava","year":"2002","unstructured":"Shristava RK, Arginteanu MS, King WA, Port KD (2002) Giant prolactinomas: clinical management and long-term follow up. J Neurosurg 97:299\u2013306","journal-title":"J Neurosurg"},{"key":"1450_CR20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11102-008-0135-1","volume":"12","author":"ME Sughrue","year":"2009","unstructured":"Sughrue ME, Chang EF, Tyrell JB, Kunwar S, Wilson CB, Blevins LS Jr (2009) Pre-operative dopamine agonist therapy improves post-operative tumor control following prolactinoma resection. Pituitary 12:158\u2013164","journal-title":"Pituitary"},{"key":"1450_CR21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1530\/eje.0.1400043","volume":"140","author":"HE Turner","year":"1999","unstructured":"Turner HE, Adams CB, Wass JA (1999) Trans-sphenoidal surgery for microprolactinoma: an acceptable alternative to dopamin agonists? Eur J Endocrinol 140:43\u201347","journal-title":"Eur J Endocrinol"},{"key":"1450_CR22","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1136\/bmj.309.6966.1409","volume":"309","author":"JA Thomson","year":"1994","unstructured":"Thomson JA, Davies DL, McLaren EH, Teasdale GM (1994) Ten year follow-up of microprolactinoma treated by transsphenoidal surgery. BMJ 309:1409","journal-title":"BMJ"},{"key":"1450_CR23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00006123-199902000-00006","volume":"44","author":"JB Tyrell","year":"1999","unstructured":"Tyrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB (1999) Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results. Neurosurgery 44:254\u2013261","journal-title":"Neurosurgery"},{"key":"1450_CR24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-2001-33619","volume":"12","author":"MY Wang","year":"2001","unstructured":"Wang MY, Weiss MH (2001) Is there a role for surgery for microprolactinomas? Semin Neurosurg 12:289\u2013294","journal-title":"Semin Neurosurg"},{"key":"1450_CR25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2165\/00002018-199614040-00003","volume":"14","author":"J Webster","year":"1996","unstructured":"Webster J (1996) A comparative review of the tolerability profiles of dopamin agonists in the treatment of hyperprolactinaemia and inhibition of lactation. Drug Saf 14:228\u2013238","journal-title":"Drug Saf"},{"key":"1450_CR26","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","volume":"331","author":"J Webster","year":"1994","unstructured":"Webster J, Piscitelli G, Polli A, Cl F, Ismail I, Scanlon MF (1994) A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinaemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med 331:904\u2013909","journal-title":"N Engl J Med"},{"key":"1450_CR27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3171\/jns.2003.98.2.0350","volume":"98","author":"G Zada","year":"2003","unstructured":"Zada G, Kelly DF, Cohan P, Wang C, Swerdloff R (2003) Endonasal transsphenoidal approach for pituitary adenomas and other sellar lesions: an assessment of efficacy, safety, and patient impressions. J Neurosurg 98:350\u2013358","journal-title":"J Neurosurg"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-012-1450-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00701-012-1450-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-012-1450-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T07:48:14Z","timestamp":1562053694000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00701-012-1450-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,3]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["1450"],"URL":"https:\/\/doi.org\/10.1007\/s00701-012-1450-x","relation":{},"ISSN":["0001-6268","0942-0940"],"issn-type":[{"value":"0001-6268","type":"print"},{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,3]]}}}